Related Experiment Video
Updated: Aug 16, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Sarcoidosis occurring after interferon-alpha therapy for chronic hepatitis C: report of two cases
Atsushi Hirano1, Mikio Kataoka, Yasunari Nakata
1Department of Internal Medicine II, Okayama University Medical School, Okayama, Japan. ka-hirano@mug.biglobe.ne.jp
Abstract:
We report two patients who were diagnosed with sarcoidosis after receiving interferon (IFN)-alpha therapy for chronic hepatitis C, and conduct a review the relevant literature. The first patient was a 52-year-old female who developed multiple subcutaneous nodules 2 months after finishing IFN-alpha therapy. A skin biopsy from subcutaneous nodules on the right elbow joint revealed sarcoid granulomata. These lesions resolved spontaneously 4 months later. The second patient, a 57-year-old male, developed bilateral hilar and mediastinal lymph node enlargement 2 years after finishing IFN-alpha 2a therapy. A transbronchial lung biopsy demonstrated sarcoid granulomata. In addition, he had uveitis and left ulnar nerve involvement. His eye and nerve involvement gradually improved over 20 months. It is feasible that IFN therapy has been a trigger for sarcoidosis in these patients.
Related Concept Videos
Hepatitis
Inhibitors of Viral Protein Synthesis
Cirrhosis II: Pathophysiology
Viral Hepatitis I: Introduction
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers